- Apfel SC. Is the therapeutic application of neurotrophic factors dead? Ann Neurol 2002; 51: 8–11
- Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 2000; 284: 2215–2221
- Araki K, Shiotani A, Watabe K, et al. Adenoviral GDNF gene transfer enhances neurofunctional recovery after recurrent laryn-geal nerve injury. Gene Ther 2006; 13: 296–303
- Azzouz M, Ralph GS, Storkebaum E, et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004; 429: 413–417
- Barati S, Hurtado PR, Zhang SH, et al. GDNF gene delivery via the p75(NTR) receptor rescues injured motor neurons. Exp Neurol 2006; 202: 179–188
- Blesch A, Conner J, Pfeifer A, et al. Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons. Mol Ther 2005; 11: 916–925
- Blesch A, Tuszynski MH. Spontaneous and neurotrophin-induced axonal plasticity after spinal cord injury. Prog Brain Res 2002; 137: 415–423
- Blesch A, Tuszynski MH. Transient growth factor delivery sustains regenerated axons after spinal cord injury. I Neurosci 2007; 27: 10535–10545
- BI its B, Carlstedt TP, Ruitenberg MJ, et al. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor. Exp Neurol 2004; 189: 303–316
- Bosse F, Hasenpusch-Theil K, Kury P, et al. Gene expression profiling reveals that peripheral nerve regeneration is a conse-quence of both novel injury-dependent and reactivated develop-mental processes. Neurochem 2006; 96: 1441–1457
- Boyd JG, Gordon T. A dose-dependent facilitation and inhibition of peripheral nerve regeneration by brain-derived neurotrophic factor. Eur J Neurosci 2002; 15: 613–626
- Boyd JG, Gordon T. Glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor sustain the axonal regeneration of chronically axotomized motoneurons in vivo. Exp Neurol 2003; 183: 610–619
- Boyd JG, Gordon T. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol 2003; 27: 277–324
- de Ruiter GC, Malessy MJ, Alaid AO, et al. Misdirection of regenerating motor axons after nerve injury and repair in the rat sciatic nerve model. Exp Neurol 2008; 211: 339–350
- Dijkhuizen PA, Pasterkamp RJ, Hermens WT, et al. Adenoviral vector-mediated gene delivery to injured rat peripheral nerve. I Neurotrauma 1998; 15: 387–397
- Dittrich F, Ochs G, Grosse-Wilde A, et al. Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons. Exp Neurol 1996; 141: 225–239
- Eriksdotter Jonhagen M, Nordberg A, Amberla K, et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord 1998; 9: 246–257
- Geller Al, Keyomarsi K, Bryan J, et a/. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology. Proc Nat! Acad Sci USA 1990; 87: 8950–8954
- Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Nat! Acad Sci USA 1992; 89: 5547–5551
- Gramsbergen A, Ijkema-Paassen J, Meek MF. Sciatic nerve transection in the adult rat: Abnormal EMG patterns during locomotion by aberrant innervation of hindleg muscles. Exp Neurol 2000; 161: 183–193
- Gravvanis Al, Lavdas A, Papalois AE, et al. Effect of genetically modified Schwann cells with increased motility in end-to-side nerve grafting. Microsurgery 2005; 25: 423–432
- Haastert K, Lipokatic E, Fischer M, et al. Differentially promoted peripheral nerve regeneration by grafted Schwann cells over-expressing different FGF-2 isoforms. Neurobiol Dis2006; 21: 138-153
- Hendriks WT, Eggers R, Carlstedt TP, et al. Lentiviral vector-mediated reporter gene expression in avulsed spinal ventral root is short-term, but is prolonged using an immune “stealth” transgene. Restor Neurol Neurosci 2007; 25: 585–599
- Hendriks WT, Ruitenberg MJ, Blits B, et al. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res 2004; 146: 451–476
- Ho DY, Mocarski ES. Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci USA 1989; 86: 7596–7600
- Hoke A. Mechanisms of disease: What factors limit the success of peripheral nerve regeneration in humans? Nat Clin Pract Neurol 2006; 2: 448–454
- Hoke A, Redett R, Hameed H, et al. Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J Neurosci 2006; 26: 9646–9655
- Jakobsson J, Ericson C, Rosenqvist N, et al. Lentiviral vectors. Int Rev Neurobiol 2003; 55: 111–122
- Jimenez CR, Stam FJ, Li KW, et al. Proteomics of the injured rat sciatic nerve reveals protein expression dynamics during regen-eration. Mol Cell Proteomics 2005; 4: 120–132
- Jubran M, Widenfalk J. Repair of peripheral nerve transections with fibrin sealant containing neurotrophic factors. Exp Neurol 2003; 181: 204–212
- Kaplitt MG, Feigin A, Tang C, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: An open label, phase I trial. Lancet 2007; 369: 2097–2105
- Kaspar BK, Llado J, Sherkat N, et al. Retrograde viral delivery of IGE-1 prolongs survival in a mouse ALS model. Science 2003; 301: 839-842
- Kemp SW, Walsh SK, Zochodne DW, et al. A novel method for establishing daily in vivo concentration gradients of soluble nerve growth factor (NGF). I Neurosci Methods 2007; 165: 83–88
- Li Q, Ping P, Jiang H, et al. Nerve conduit filled with GDNF gene-modified Schwann cells enhances regeneration of the peripheral nerve. Microsurgery 2006; 26: 116–121
- Lundborg G. A 25-year perspective of peripheral nerve surgery: Evolving neuroscientific concepts and clinical significance.] Hand Surg [Am] 2000; 25: 391–414
- Maggi SP, Lowe JB 3rd, Mackinnon SE. Pathophysiology of nerve injury. Clin Plast Surg 2003; 30: 109–126
- Mann R, Mulligan RC, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33: 153–159
- Mazarakis ND, Azzouz M, Rohll JB, et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 2001; 10: 2109–2121
- Moore K, MacSween M, Shoichet M. Immobilized concentration gradients of neurotrophic factors guide neurite outgrowth of primary neurons in macroporous scaffolds. Tissue Eng 2006; 12: 267–278
- Moro K, Shiotani A, Watabe K, et al. Adenoviral gene transfer of BDNF and GDNF synergistically prevent motoneuron loss in the nucleus ambiguus. Brain Res 2006; 1076: 1–8
- Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263–267
- Nguyen QT, Sanes JR, Lichtman JW. Pre-existing pathways promote precise projection patterns. Nat Neurosci 2002; 5: 861–867
- Perez MC, Hunt SP, Coffin RS, et al. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo. Gene Ther 2004; 11: 1023–1032
- Pezet S, McMahon SB. Neurotrophins: Mediators and modulators of pain. Annu Rev Neurosci 2006; 29: 507–538
- Sakamoto T, Kawazoe Y, Shen JS, etal. Adenoviral gene transfer of GDNF, BDNF and TGF beta 2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motoneurons after facial nerve avulsion. J Neurosci Res 2003; 72: 54–64
- Senn C, Fraefel C, Breakefield XO. HSV ampl icon vectors for gene delivery to the nervous system. In: Kaplitt MG, During MJ, eds. Gene Therapy in the Central Nervous System, Boston, MA: Academic Press, 2006: pp. 25–38
- Stam FJ, MacGillavry HD, Armstrong Ni, et al. Identification of candidate transcriptional modulators involved in successful regeneration after nerve injury. Eur I Neurosci 2007; 25: 3629–3637
- Sunderland S. Nerve Injuries and Their Repair: A Critical Appraisal, Melbourne: Chuchill Livingstone, 1991
- Tannemaat MR, Boer GJ, Verhaagen J, et al. Genetic modification of human sural nerve segments by a lentiviral vector encoding nerve growth factor. Neurosurgery 2007; 61: 1286–1294
- Taylor L, Jones L, Tuszynski MH, et al. Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord. Neurosci 2006; 26: 9713–9721
- Timmer M, Robben S, Muller-Ostermeyer F, et al. Axonal regeneration across long gaps in silicone chambers filled with Schwann cells overexpressing high molecular weight FGF-2. Cell Transplant 2003; 12: 265–277
- Tria MA, Fusco M, Vantini G, et al. Pharmacokinetics of nerve growth factor (NGF) following different routes of administration to adult rats. Exp Neurol 1994; 127: 178–183
- Tuszynski MH, Thal L, Pay M, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 2005; 11: 551–555
- Watanabe TS, Ohtori S, Koda M, et al. Adenoviral gene transfer in the peripheral nervous system. I Orthop Sci 2006; 11: 64–69
- Wu Z, Asokan A, Samulski RJ. Adeno-associated virus serotypes: Vector toolkit for human gene therapy. Mol Ther 2006; 14: 316–327
- Xu Y, Gu Y, Wu P, et al. Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Hum Gene Ther 2003; 14: 897–906
- Yin Q, Kemp GJ, Yu LG, etal. Neurotrophin-4 delivered by fibrin glue promotes peripheral nerve regeneration. Muscle Nerve 2001; 24: 345–351
- Young C, Miller E, Nicklous DM, et al. Nerve growth factor and neurotrophin-3 affect functional recovery following peripheral nerve injury differently. Restor Neurol Neurosci 2001; 18: 167–175
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 30, 2008 - Issue 10: Nerve Regeneration and Nerve Repair